Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis.
Menstrual blood offers a non-invasive way to screen for cervical cancer, potentially reaching people who skip doctor visits.
This randomized controlled trial evaluates Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis. The PubMed abstract reports that CONCLUSIONS: MB-based HPV testing demonstrates high diagnostic accuracy and emerges as a non-invasive alternative for cervical cancer screening, especially in underserved settings.
What the study was
- Study design
- Randomized controlled trial
- Population
- Human participants described in the PubMed abstract
- Sample size
- 1297
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Advances in medical sciences
Why it surfaced
Randomized controlled trial with human evidence; scored conservatively from PubMed abstract-level metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.